The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells

The hormone oxytocin (OT) has pleiotropic activities both in the central nervous system as well as in peripheral tissues, including uterotonic effects on the myometrium during parturition. OT effects are mediated by a single transmembrane receptor, belonging to the GPCR (G protein-coupled receptor)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular signalling 2022-02, Vol.90, p.110211-110211, Article 110211
Hauptverfasser: Devost, Dominic, Zingg, Hans H., Hébert, Terence E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 110211
container_issue
container_start_page 110211
container_title Cellular signalling
container_volume 90
creator Devost, Dominic
Zingg, Hans H.
Hébert, Terence E.
description The hormone oxytocin (OT) has pleiotropic activities both in the central nervous system as well as in peripheral tissues, including uterotonic effects on the myometrium during parturition. OT effects are mediated by a single transmembrane receptor, belonging to the GPCR (G protein-coupled receptor) superfamily and coupled primarily to Gq- and Gi-containing heterotrimeric G proteins. Upon receptor stimulation, one well-studied downstream effect is activation of the ERK1/2 MAP (mitogen-activated protein) kinase, and studies have shown that induction of COX-2 by OT in the myometrium required ERK1/2 activity. Many studies investigating the role of ERK1/2 in myometrial tissue were based on the use of chemical inhibitors that, to varying degrees, also inhibited ERK5/MAPK7. Here we report that OT activates ERK5 in a human myometrial cell line in a dose- and time-dependent manner through the activation of Gi/o heterotrimers. Using complementary approaches, we demonstrate that OT-induced COX-2 induction and the concomitant release of PGF2α into the media are primarily ERK5-dependent and to a much lesser extent ERK1/2-dependent. Moreover, in contrast to ERK1/2 activation, ERK5 activation is downstream of Gi/o activation. Here, we also found that ERK5 impacted both basal and to a lesser extent, OT-mediated myometrial cell contraction in vitro. Finally, tracking both ERK1/2 and ERK5 activity during different stages of gestation in rat myometrium, we showed that they followed distinct patterns starting at the onset of labor corresponding to the highest COX-2 expression levels. Overall, our results reveal an important, hitherto unrecognized role for ERK5 in myometrial cell contraction involving induction of COX-2. This novel pathway is likely to play an important role in supporting uterine contractions during parturition. •The peptide hormone oxytocin activates the ERK5 MAP kinase in myometrial cells.•ERK5 plays an important role in OT-induced COX-2 expression through a PTX-sensitive pathway•ERK5 is involved in myometrial cell contraction•ERK5 activation and COX-2 expression are correlated in the myometrium during parturition in rats.
doi_str_mv 10.1016/j.cellsig.2021.110211
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2610074335</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0898656821003004</els_id><sourcerecordid>2610074335</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-fac9b4c605395e2c2d2936d8e0b85aacea09883aa0b999f64d394d65d09162bb3</originalsourceid><addsrcrecordid>eNqFkE9PGzEQxS3UqgnQjwDykcsm_rN21qcKoUBRUrVC6a2S5bVng9PdNdgbaL59HRJ67WVGI7038-aH0AUlE0qonG4mFto2-fWEEUYnlOZKT9CYVjNecEX5BzQmlaoKKWQ1QqcpbQihgkj2CY14qQgTJRujX6tHwN-uf-DfvjcJ8PxhIaZ5XsywT9hgF177NEQwHYamATuEiEODw5_dEKzvcQ7Qm9b3a5yHbhc6GKI3LX4Ld44-NqZN8PnYz9DP2_nq5mux_H53f3O9LCyXYigaY1VdWkkEVwKYZY4pLl0FpK6EMRYMUVXFjSG1UqqRpeOqdFI4oqhkdc3P0NVh71MMz1tIg-582icwPYRt0kxSQmYl5yJLxUFqY0gpQqOfou9M3GlK9B6s3ugjWL0Hqw9gs-_yeGJbd-D-ud5JZsGXgwDyoy8eok7WQ2_B-ZixaRf8f078BUFLiwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610074335</pqid></control><display><type>article</type><title>The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Devost, Dominic ; Zingg, Hans H. ; Hébert, Terence E.</creator><creatorcontrib>Devost, Dominic ; Zingg, Hans H. ; Hébert, Terence E.</creatorcontrib><description>The hormone oxytocin (OT) has pleiotropic activities both in the central nervous system as well as in peripheral tissues, including uterotonic effects on the myometrium during parturition. OT effects are mediated by a single transmembrane receptor, belonging to the GPCR (G protein-coupled receptor) superfamily and coupled primarily to Gq- and Gi-containing heterotrimeric G proteins. Upon receptor stimulation, one well-studied downstream effect is activation of the ERK1/2 MAP (mitogen-activated protein) kinase, and studies have shown that induction of COX-2 by OT in the myometrium required ERK1/2 activity. Many studies investigating the role of ERK1/2 in myometrial tissue were based on the use of chemical inhibitors that, to varying degrees, also inhibited ERK5/MAPK7. Here we report that OT activates ERK5 in a human myometrial cell line in a dose- and time-dependent manner through the activation of Gi/o heterotrimers. Using complementary approaches, we demonstrate that OT-induced COX-2 induction and the concomitant release of PGF2α into the media are primarily ERK5-dependent and to a much lesser extent ERK1/2-dependent. Moreover, in contrast to ERK1/2 activation, ERK5 activation is downstream of Gi/o activation. Here, we also found that ERK5 impacted both basal and to a lesser extent, OT-mediated myometrial cell contraction in vitro. Finally, tracking both ERK1/2 and ERK5 activity during different stages of gestation in rat myometrium, we showed that they followed distinct patterns starting at the onset of labor corresponding to the highest COX-2 expression levels. Overall, our results reveal an important, hitherto unrecognized role for ERK5 in myometrial cell contraction involving induction of COX-2. This novel pathway is likely to play an important role in supporting uterine contractions during parturition. •The peptide hormone oxytocin activates the ERK5 MAP kinase in myometrial cells.•ERK5 plays an important role in OT-induced COX-2 expression through a PTX-sensitive pathway•ERK5 is involved in myometrial cell contraction•ERK5 activation and COX-2 expression are correlated in the myometrium during parturition in rats.</description><identifier>ISSN: 0898-6568</identifier><identifier>EISSN: 1873-3913</identifier><identifier>DOI: 10.1016/j.cellsig.2021.110211</identifier><identifier>PMID: 34902542</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Animals ; ERK1/2 ; ERK5 ; Female ; MAP kinase ; MAPK7 ; Myometrial cells ; Myometrium - metabolism ; Oxytocin - metabolism ; Oxytocin receptor ; Pregnancy ; Rats ; Receptors, Oxytocin - metabolism ; Signal Transduction ; Uterine Contraction</subject><ispartof>Cellular signalling, 2022-02, Vol.90, p.110211-110211, Article 110211</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-fac9b4c605395e2c2d2936d8e0b85aacea09883aa0b999f64d394d65d09162bb3</citedby><cites>FETCH-LOGICAL-c365t-fac9b4c605395e2c2d2936d8e0b85aacea09883aa0b999f64d394d65d09162bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cellsig.2021.110211$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27925,27926,45996</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34902542$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Devost, Dominic</creatorcontrib><creatorcontrib>Zingg, Hans H.</creatorcontrib><creatorcontrib>Hébert, Terence E.</creatorcontrib><title>The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells</title><title>Cellular signalling</title><addtitle>Cell Signal</addtitle><description>The hormone oxytocin (OT) has pleiotropic activities both in the central nervous system as well as in peripheral tissues, including uterotonic effects on the myometrium during parturition. OT effects are mediated by a single transmembrane receptor, belonging to the GPCR (G protein-coupled receptor) superfamily and coupled primarily to Gq- and Gi-containing heterotrimeric G proteins. Upon receptor stimulation, one well-studied downstream effect is activation of the ERK1/2 MAP (mitogen-activated protein) kinase, and studies have shown that induction of COX-2 by OT in the myometrium required ERK1/2 activity. Many studies investigating the role of ERK1/2 in myometrial tissue were based on the use of chemical inhibitors that, to varying degrees, also inhibited ERK5/MAPK7. Here we report that OT activates ERK5 in a human myometrial cell line in a dose- and time-dependent manner through the activation of Gi/o heterotrimers. Using complementary approaches, we demonstrate that OT-induced COX-2 induction and the concomitant release of PGF2α into the media are primarily ERK5-dependent and to a much lesser extent ERK1/2-dependent. Moreover, in contrast to ERK1/2 activation, ERK5 activation is downstream of Gi/o activation. Here, we also found that ERK5 impacted both basal and to a lesser extent, OT-mediated myometrial cell contraction in vitro. Finally, tracking both ERK1/2 and ERK5 activity during different stages of gestation in rat myometrium, we showed that they followed distinct patterns starting at the onset of labor corresponding to the highest COX-2 expression levels. Overall, our results reveal an important, hitherto unrecognized role for ERK5 in myometrial cell contraction involving induction of COX-2. This novel pathway is likely to play an important role in supporting uterine contractions during parturition. •The peptide hormone oxytocin activates the ERK5 MAP kinase in myometrial cells.•ERK5 plays an important role in OT-induced COX-2 expression through a PTX-sensitive pathway•ERK5 is involved in myometrial cell contraction•ERK5 activation and COX-2 expression are correlated in the myometrium during parturition in rats.</description><subject>Animals</subject><subject>ERK1/2</subject><subject>ERK5</subject><subject>Female</subject><subject>MAP kinase</subject><subject>MAPK7</subject><subject>Myometrial cells</subject><subject>Myometrium - metabolism</subject><subject>Oxytocin - metabolism</subject><subject>Oxytocin receptor</subject><subject>Pregnancy</subject><subject>Rats</subject><subject>Receptors, Oxytocin - metabolism</subject><subject>Signal Transduction</subject><subject>Uterine Contraction</subject><issn>0898-6568</issn><issn>1873-3913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE9PGzEQxS3UqgnQjwDykcsm_rN21qcKoUBRUrVC6a2S5bVng9PdNdgbaL59HRJ67WVGI7038-aH0AUlE0qonG4mFto2-fWEEUYnlOZKT9CYVjNecEX5BzQmlaoKKWQ1QqcpbQihgkj2CY14qQgTJRujX6tHwN-uf-DfvjcJ8PxhIaZ5XsywT9hgF177NEQwHYamATuEiEODw5_dEKzvcQ7Qm9b3a5yHbhc6GKI3LX4Ld44-NqZN8PnYz9DP2_nq5mux_H53f3O9LCyXYigaY1VdWkkEVwKYZY4pLl0FpK6EMRYMUVXFjSG1UqqRpeOqdFI4oqhkdc3P0NVh71MMz1tIg-582icwPYRt0kxSQmYl5yJLxUFqY0gpQqOfou9M3GlK9B6s3ugjWL0Hqw9gs-_yeGJbd-D-ud5JZsGXgwDyoy8eok7WQ2_B-ZixaRf8f078BUFLiwA</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Devost, Dominic</creator><creator>Zingg, Hans H.</creator><creator>Hébert, Terence E.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202202</creationdate><title>The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells</title><author>Devost, Dominic ; Zingg, Hans H. ; Hébert, Terence E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-fac9b4c605395e2c2d2936d8e0b85aacea09883aa0b999f64d394d65d09162bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>ERK1/2</topic><topic>ERK5</topic><topic>Female</topic><topic>MAP kinase</topic><topic>MAPK7</topic><topic>Myometrial cells</topic><topic>Myometrium - metabolism</topic><topic>Oxytocin - metabolism</topic><topic>Oxytocin receptor</topic><topic>Pregnancy</topic><topic>Rats</topic><topic>Receptors, Oxytocin - metabolism</topic><topic>Signal Transduction</topic><topic>Uterine Contraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Devost, Dominic</creatorcontrib><creatorcontrib>Zingg, Hans H.</creatorcontrib><creatorcontrib>Hébert, Terence E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cellular signalling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Devost, Dominic</au><au>Zingg, Hans H.</au><au>Hébert, Terence E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells</atitle><jtitle>Cellular signalling</jtitle><addtitle>Cell Signal</addtitle><date>2022-02</date><risdate>2022</risdate><volume>90</volume><spage>110211</spage><epage>110211</epage><pages>110211-110211</pages><artnum>110211</artnum><issn>0898-6568</issn><eissn>1873-3913</eissn><abstract>The hormone oxytocin (OT) has pleiotropic activities both in the central nervous system as well as in peripheral tissues, including uterotonic effects on the myometrium during parturition. OT effects are mediated by a single transmembrane receptor, belonging to the GPCR (G protein-coupled receptor) superfamily and coupled primarily to Gq- and Gi-containing heterotrimeric G proteins. Upon receptor stimulation, one well-studied downstream effect is activation of the ERK1/2 MAP (mitogen-activated protein) kinase, and studies have shown that induction of COX-2 by OT in the myometrium required ERK1/2 activity. Many studies investigating the role of ERK1/2 in myometrial tissue were based on the use of chemical inhibitors that, to varying degrees, also inhibited ERK5/MAPK7. Here we report that OT activates ERK5 in a human myometrial cell line in a dose- and time-dependent manner through the activation of Gi/o heterotrimers. Using complementary approaches, we demonstrate that OT-induced COX-2 induction and the concomitant release of PGF2α into the media are primarily ERK5-dependent and to a much lesser extent ERK1/2-dependent. Moreover, in contrast to ERK1/2 activation, ERK5 activation is downstream of Gi/o activation. Here, we also found that ERK5 impacted both basal and to a lesser extent, OT-mediated myometrial cell contraction in vitro. Finally, tracking both ERK1/2 and ERK5 activity during different stages of gestation in rat myometrium, we showed that they followed distinct patterns starting at the onset of labor corresponding to the highest COX-2 expression levels. Overall, our results reveal an important, hitherto unrecognized role for ERK5 in myometrial cell contraction involving induction of COX-2. This novel pathway is likely to play an important role in supporting uterine contractions during parturition. •The peptide hormone oxytocin activates the ERK5 MAP kinase in myometrial cells.•ERK5 plays an important role in OT-induced COX-2 expression through a PTX-sensitive pathway•ERK5 is involved in myometrial cell contraction•ERK5 activation and COX-2 expression are correlated in the myometrium during parturition in rats.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>34902542</pmid><doi>10.1016/j.cellsig.2021.110211</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0898-6568
ispartof Cellular signalling, 2022-02, Vol.90, p.110211-110211, Article 110211
issn 0898-6568
1873-3913
language eng
recordid cdi_proquest_miscellaneous_2610074335
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
ERK1/2
ERK5
Female
MAP kinase
MAPK7
Myometrial cells
Myometrium - metabolism
Oxytocin - metabolism
Oxytocin receptor
Pregnancy
Rats
Receptors, Oxytocin - metabolism
Signal Transduction
Uterine Contraction
title The MAP kinase ERK5/MAPK7 is a downstream effector of oxytocin signaling in myometrial cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T15%3A05%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20MAP%20kinase%20ERK5/MAPK7%20is%20a%20downstream%20effector%20of%20oxytocin%20signaling%20in%20myometrial%20cells&rft.jtitle=Cellular%20signalling&rft.au=Devost,%20Dominic&rft.date=2022-02&rft.volume=90&rft.spage=110211&rft.epage=110211&rft.pages=110211-110211&rft.artnum=110211&rft.issn=0898-6568&rft.eissn=1873-3913&rft_id=info:doi/10.1016/j.cellsig.2021.110211&rft_dat=%3Cproquest_cross%3E2610074335%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2610074335&rft_id=info:pmid/34902542&rft_els_id=S0898656821003004&rfr_iscdi=true